
Hospitals are essential to inpatient care, and are playing an increasingly important role in outpatient care as well. It is therefore no wonder that in the developed, industrialised countries, this cost-intensive component of healthcare is increasingly the focus of efforts to improve quality and cut costs. But what should a high-quality, economical system for supplying medical products to hospitals look like? A long-term study conducted by the Fraunhofer IIS -Center for Applied Research on Supply Chain Services has been examining this question. Dr. Johannes Kriegel, who initiated the study, and Franziska Jehler of the Fraunhofer SCS describe the key areas where potential improvements could be made.

The legal right to delivery for wholesalers in Germany has left many pharmaceutical companies faced with the question: What do we do now? Peter Behner Partner at Booz & Company and expert in pharmaceutical distribution comments on the results of the 15th amendment to the Medical Preparations Act in Germany and explains what the key issues will be in future.

The recall must take effect fast to avoid possible risks to patients and to prevent long-term damage to the manufacturer’s image. A complete recall of one or more products is usually indispensable. In this case, all processes must be structured and reliably intermeshed to guarantee that each affected product is withdrawn from circulation. To ensure that this happens, we at arvato services healthcare define the sequence of all required steps in advance, right down to the last detail.

Thanks to rising customer demand, the arvato services healthcare site in Monheim near Düsseldorf, with a total storage area of 6,000 m2, has developed particular expertise in the handling of hazardous goods in recent years. Category 2 (gases), 3 (inflammable materials), 6 (poisons), 8 (caustic materials), and 9 (various material characteristics) hazardous goods are currently stored, packaged and shipped in conformance with hazardous material requirements in an area covering 600 m².